General
Preferred name
MILTEFOSINE
Synonyms
MILTEFOSINE [5mM] ()
NSC605583 ()
HEPC ()
Hexadecyl phosphocholine ()
Miltex ()
Hexadecylphosphocholine ()
NSC-605583 ()
Miltefosina ()
D-18506 ()
Impavido ()
NSC-758968 ()
Miltefosine-d4 ()
P&D ID
PD000933
CAS
58066-85-6
Tags
available
drug
Approved by
FDA
First approval
2014
Drug indication
Leishmaniasis
Visceral leishmaniasis
Drug Status
approved
investigational
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Miltefosine is an antiprotozoal (anthelmintic) drug that is primarily used to treat leishmaniasis. It has additional anticancer and immunomodulatory/anti-inflammatory activities . The antitumour activity of miltefosine is principally mediated through the inhibition of Akt phosphorylation , which exerts a modulatory effect on the phosphatidylinositol 3-kinase (PI3K)-Akt/PKB cellular survival pathway. (GtoPdb)
PRICE 29
DESCRIPTION Miltefosine is an antileishmanial agent used to treat leishmaniasis. (Enamine Bioactive Compounds)
DESCRIPTION Miltefosine (HePC) is the treatment of visceral and cutaneous leishmaniasis drug , and is proceeding clinical trials for this in several countries. Several medical agents produce some potency against visceral or cutaneous leishmaniasis, however a 2005 survey concluded that miltefosine is the only effective oral treatment for both forms of leishmaniasis. (TargetMol Bioactive Compound Library)
Cell lines
25
Organisms
18
Compound Sets
27
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Bioprocess diversity set
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
Natural product-based probes and drugs
NCATS Inxight Approved Drugs
NIH Mechanistic Set
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Pathogen Box
The Spectrum Collection
External IDs
97
Properties
(calculated by RDKit )
Molecular Weight
407.32
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
0
Rotatable Bonds
20
Ring Count
0
Aromatic Ring Count
0
cLogP
5.68
TPSA
58.59
Fraction CSP3
1.0
Chiral centers
1.0
Largest ring
0.0
QED
0.15
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Biological process
Resipration, oxidative phosphorylation, & mitochondrial targeting
Disease
REFERENCE COMPOUNDS
Target
Akt
HIV
PKC
Parasite
MOA
PKC inhibitor
Akt inhibitor
Biosynthetic Origin
Fatty Acid
Therapeutic Indication
Anticancer
Pathway
Chromatin/Epigenetic
Cytoskeletal Signaling
Microbiology/virology
PI3K/Akt/mTOR signaling
Proteases/Proteasome
Anti-infection
PI3K/Akt/mTOR
Therapeutic Class
Antifungal Agents
Source data